Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure

European Journal of Internal Medicine

Volumn 23, Issue 6, 2012, Pages 545-551

  Aispuru, Gualberto Rodrigo ^a,b   Clavier, Marcel María ^a   Cardone, Alberto José ^a   Gilberto, Daniel Oscar ^a,b   Barousse, Amadeo Pedro ^a,c  

^a Casa Hospital San Juan de Dios   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Deep vein thrombosis; Pulmonary embolism; Thromboprophylaxis

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIOEMBOLIC STROKE; CARDIOMYOPATHY; DEEP VEIN THROMBOSIS; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE SIZE; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROGNOSIS; PROTEIN BLOOD LEVEL; SYSTOLIC DYSFUNCTION; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ENOXAPARIN; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PULMONARY EMBOLISM; STROKE VOLUME; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 84864591137     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.04.002     Document Type: Article

References (42)

1. R.S. Freudenberger, M.M. Schumaecker, and S. Homma What is the appropriate approach to prevention of thromboembolism in heart failure? Thromb Haemost 103 2010 489 495
2. R.S. Freudenberger, A.S. Hellkamp, J.L. Halperin, J. Poole, J. Anderson, and G. Johnson SCD-HeFT investigators. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation 115 2007 2637 2641 (Pubitemid 46791362)
3. W.B. Dunkman, G.R. Johnson, P.E. Carson, G. Bhat, L. Farrell, and J.N. Cohn Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA cooperative studies group Circulation 87 1993 94 101
4. D.L. Dries, Y.D. Rosenberg, M.A. Waclawiw, and M.J. Domanski Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials J Am Coll Cardiol 29 1997 1074 1080 (Pubitemid 27149584)
5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
6. R. Virchow Gesammelte Abhandlungen zur Wissenschaftlichen Medicine 1856 Meidinger Sohn & Co. Frankfurt 219 732
7. G.Y. Lip, and C.R. Gibbs Does heart failure confer a hypercoagulable state? Virchow's triad revisited J Am Coll Cardiol 33 1999 1424 1426
8. A. Mongirdiene, L. Kursvietiene, and A. Kasauskas The coagulation system changes in patients with chronic heart failure Medicina (Kaunas) 46 2010 642 647
9. A.S. Abdo, R. Kemp, J. Barham, and S.A. Geraci Dilated cardiomyopathy and role of antithrombotic therapy Am J Med Sci 339 2010 557 560
10. L.S. Koniaris, and S.Z. Goldhaber Anticoagulation in dilated cardiomyopathy J Am Coll Cardiol 31 1998 745 748 (Pubitemid 28186405)
11. E.V. Shlyakhto, K.A. Khmelnitskaya, M.U. Sitnikova, and S.G. Ivanov Endothelium dependent prothrombotic and fibrinolytic factors in patients with ischemic heart disease and chronic heart failure Atherosclerosis 10 2009 549
12. M. Cugno, D. Mari, P.L. Meroni, E. Gronda, F. Vicari, and M. Frigerio Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation Br J Haematol 126 2004 85 92 (Pubitemid 38859487)
13. U. Alehagen, U. Dahlstrom, and T.L. Lindahl Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure Thromb Haemost 92 2004 250 258
14. S.M. Jafri, T. Ozawa, E. Mammen, T.B. Levine, C. Johnson, and S. Goldstein Platelet function, thrombin and fibrinolytic activity in patients with heart failure Eur Heart J 14 1993 205 212 (Pubitemid 23089506)
15. B. Jug, N. Vene, B.G. Salobir, M. Sebestjen, M. Sabovic, and I. Keber Prognostic impact of haemostatic derangements in chronic heart failure Thromb Haemost 102 2009 314 320
16. E. Sbarouni, A. Bradshaw, F. Andreotti, E. Tuddenham, C.M. Oakley, and J.G. Cleland Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure Am Heart J 127 1994 607 612 (Pubitemid 24124691)
17. E.S. Darze, A.L. Latado, A.G. Guimarães, R.A. Guedes, A.B. Santos, and S.S. de Moura Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit Chest 128 2005 2576 2580 (Pubitemid 41507611)
18. R. Alikhan, A.T. Cohen, S. Combe, M.M. Samama, L. Desjardins, and A. Eldor MEDENOX study. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness Arch Intern Med 164 2004 963 968 (Pubitemid 38581515)
19. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115 (Pubitemid 23195439)
20. P.A. McCullough, R.M. Nowak, J. McCord, J.E. Hollander, H.C. Herrmann, and P.G. Steg B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study Circulation 106 2002 416 422 (Pubitemid 34803684)
21. K.L. Baughman B-type natriuretic peptide - a window to the heart N Engl J Med 347 2002 158 159 (Pubitemid 34764818)
22. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 381 453
23. F.X. Kleber, C. Witt, G. Vogel, K. Koppenhagen, U. Schomaker, and C.W. Flosbach THE-PRINCE Study Group. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease Am Heart J 145 2003 614 621 (Pubitemid 36403489)
24. A.M. Choy, D. Darbar, C.C. Lang, T.H. Pringle, G.P. McNeill, and N.S. Kennedy Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods Br Heart J 72 1994 16 22 (Pubitemid 24245380)
25. J.M. Brennan, J.E. Blair, S. Goonewardena, A. Ronan, D. Shah, and S. Vasaiwala Reappraisal of the use of inferior vena cava for estimating right atrial pressure J Am Soc Echocardiogr 20 2007 857 861 (Pubitemid 47016906)
26. C. Hotoleanu, D. Fodor, and O. Suciu Correlations between clinical probability and Doppler ultrasound results in the assessment of deep venous thrombosis Med Ultrason 12 2010 17 21
27. S. Konstantinides Acute pulmonary embolism N Engl J Med 359 2008 2804 2813
28. H.B. Van der Worp, and J. van Gijn Clinical practice. Acute ischemic stroke N Engl J Med 357 2007 572 579 (Pubitemid 47236282)
29. W.B. Dunkman, G.R. Johnson, P.E. Carson, G. Bhat, L. Farrell, and J.N. Cohn Incidence of thromboembolicevents in congestive heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 94 101
30. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 1987 1429 1435
31. P. Prandoni Acquired risk factors of venous thromboembolism in medical patients Pathophysiol Haemost Thromb 35 2006 128 132
32. S. Ota, N. Yamada, A. Tsuji, K. Ishikura, M. Nakamura, and M. Ito Incidence and clinical predictors of deep vein thrombosis in patients hospitalized with heart failure in Japan Circ J 73 2009 1513 1517
33. P.S. Wells, D.R. Anderson, M. Rodger, J.S. Ginsberg, C. Kearon, and M. Gent Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer Thromb Haemost 83 2000 416 420 (Pubitemid 30148355)
34. C.J. Davis, P.A. Gurbel, W.A. Gattis, S.Y. Fuzaylov, G.V. Nair, and C.M. O'Connor Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge Int J Cardiol 75 2000 15 21
35. K.K. Witte, S.J. Ford, T. Preston, J.D. Parker, and A.L. Clark Fibrinogen synthesis is increased in cachectic patients with chronic heart failure Int J Cardiol 129 2008 363 367
36. R.T. Yan, V. Fernandes, A.T. Yan, M. Cushman, A. Redheuil, and R. Tracy Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J 160 2010 479 486
37. J. Kelly, A. Rudd, R.G. Lewis, and B.J. Hunt Plasma D-dimers in the diagnosis of venous thromboembolism Arch Intern Med 162 2002 747 756 (Pubitemid 34273296)
38. J. Fan, X. Li, Y. Cheng, C. Yao, and N. Zhong Investigators Group. Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China Clin Invest Med 34 2011 96 104
39. B. Wiman, and A. Hamsten The fibrinolytic enzyme system and its role in the etiology of thrombo-embolic disease Semin Thromb Hemost 26 1990 207 216 (Pubitemid 20289927)
40. K. Khmelnickaya, E.V. Shlyakhto, and H.Y. Sitnikova Left ventricular aneurysm and endothelium-dependent hemostasis in patients with chronic heart failure J Clin Lipidol 2 2008 395 396
41. I. Palka, J. Nessler, B. Nessler, W. Piwowarska, W. Tracz, and A. Undas Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism Heart 96 2010 1114 1118
42. R. Isnard, and M. Komajda Thromboembolism in heart failure, old ideas and new challenges Eur J Heart Fail 3 2001 265 269 (Pubitemid 32895833)